InsiderClue

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 0/25
Result 23,301 decisions over 12 months
Reset filters
Direction ?
Both23,301 Bought585 Sold22,716
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Plan: Scheduled (10b5-1)
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
AKBA Akebia Therapeutics, Inc.
2 Feb 2026
Rucci Carolyn M.
SVP, Chief Legal Officer
Sold on a plan 3×
69,772
$96.98K
10.6%
AKBA Akebia Therapeutics, Inc.
2 Feb 2026
Burke Steven Keith
SVP, Chief Medical Officer
Sold on a plan 3×
67,658
$94.04K
6.7%
ARQT Arcutis Biotherapeutics, Inc.
2 Feb 2026
Burnett Patrick
See Remarks
Sold on a plan
3,675
$93.71K
3.9%
LGND LIGAND PHARMACEUTICALS INC
2 Feb 2026
KOZARICH JOHN W
Director
Sold on a plan 5×
467
$91.49K
1.1%
DAVE Dave Inc./DE
2 Feb 2026
POPE MICHAEL W
Director
Sold on a plan
544
$88.13K
8.5%
HURN Huron Consulting Group Inc.
2 Feb 2026
MCCARTNEY JOHN
Director
Sold on a plan
500
$84.39K
1.2%
SION Sionna Therapeutics, Inc.
2 Feb 2026
ORBIMED ADVISORS LLC
Director indirect
Sold on a plan
1,890
$84.24K
0.1%
SION Sionna Therapeutics, Inc.
2 Feb 2026
Thompson Peter A.
Director indirect
Sold on a plan
1,890
$84.24K
0.1%
PCRX Pacira BioSciences, Inc.
2 Feb 2026
RIKER LAUREN
Senior Vice President, Finance
Sold on a plan
4,000
$83.24K
7.1%
MAX MediaAlpha, Inc.
2 Feb 2026
Yi Steven
See Remarks
Sold on a plan
8,000
$82.55K
0.3%
FENC FENNEC PHARMACEUTICALS INC.
2 Feb 2026
Raykov Rosty
Director
Sold on a plan
10,349
$80.31K
9.5%
AIP Arteris, Inc.
2 Feb 2026
Alpern Paul L
VP and General Counsel
Sold on a plan
5,000
$77.38K
8.0%
DOCS Doximity, Inc.
2 Feb 2026
Wampler Kira Scherer
Director
Sold on a plan
2,000
$74.66K
9.2%
RARE Ultragenyx Pharmaceutical Inc.
2 Feb 2026
Horn Howard
Chief Financial Officer
Sold on a plan
3,061
$72.12K
3.3%
IPGP IPG PHOTONICS CORP
2 Feb 2026
Meurice Eric
Director
Sold on a plan
750
$71.25K
3.2%
DGXX Digi Power X Inc.
2 Feb 2026
Amar Alec
President
Sold on a plan
27,500
$69.58K
2.1%
MAX MediaAlpha, Inc.
2 Feb 2026
Nonko Eugene
Director indirect
Sold on a plan
6,700
$69.38K
0.5%
AKBA Akebia Therapeutics, Inc.
2 Feb 2026
Malabre Richard C
SVP, Chief Accounting Officer
Sold on a plan 2×
49,524
$68.84K
14.2%
HURN Huron Consulting Group Inc.
2 Feb 2026
SAWYER HUGH E III
Director
Sold on a plan
400
$67.51K
1.9%
NOC Northrop Grumman
2 Feb 2026
WELSH MARK A III
Director
Sold on a plan 12×
95
$65.03K
2.2%
NTGR NETGEAR, INC.
2 Feb 2026
Badjate Pramod
President & GM, NFB
Sold on a plan
3,000
$62.91K
2.0%
PLTR Palantir Technologies
2 Feb 2026
Stat Lauren Elaina Friedman
Director
Sold on a plan
400
$60.46K
0.7%
TRAK ReposiTrak, Inc.
2 Feb 2026
FIELDS RANDALL K
CHIEF EXECUTIVE OFFICER indirect
Sold on a plan 2×
5,500
$58.94K
4.4%
MAX MediaAlpha, Inc.
2 Feb 2026
Nonko Eugene
Director
Sold on a plan
5,400
$55.91K
0.6%
CYTK CYTOKINETICS INC
2 Feb 2026
Callos Andrew
EVP, Chief Commercial Officer
Sold on a plan
886
$55.02K
1.7%
CARG CarGurus, Inc.
2 Feb 2026
Elshareef Ismail
Chief Product Officer
Sold on a plan
1,645
$52.99K
1.8%
ARQT Arcutis Biotherapeutics, Inc.
2 Feb 2026
Edwards Larry Todd
See Remarks
Sold on a plan
2,052
$52.32K
1.4%
EGAN EGAIN Corp
2 Feb 2026
SMIT ERIC
Chief Financial Officer
Sold on a plan
5,000
$51.25K
3.7%
PINS PINTEREST, INC.
2 Feb 2026
Ducard Malik
Chief Content Officer
Sold on a plan
2,293
$50.58K
0.3%
AKBA Akebia Therapeutics, Inc.
2 Feb 2026
Ostrowski Erik
SVP, CFO, CBO & Treasurer
Sold on a plan
34,951
$48.58K
4.9%
SFIX Stitch Fix, Inc.
2 Feb 2026
Lake Katrina
Director indirect
Sold on a plan
8,835
$44.23K
100%
PEGA PEGASYSTEMS INC
2 Feb 2026
STILLWELL KENNETH
COO, CFO
Sold on a plan
1,000
$43.69K
0.8%
EXFY Expensify, Inc.
2 Feb 2026
Barrett David Michael
Chief Executive Officer indirect
Sold on a plan
30,000
$43.50K
2.2%
TRU TransUnion
2 Feb 2026
Skinner Todd C.
President, International
Sold on a plan
500
$39.40K
1.6%
KNSA Kiniksa Pharmaceuticals International, plc
2 Feb 2026
Quart Barry D
Director
Sold on a plan
830
$37.35K
6.2%
VEL Velocity Financial, Inc.
2 Feb 2026
Taylor Jeffrey T.
Executive VP, Capital Markets
Sold on a plan
1,772
$36.02K
1.0%
XMTR Xometry, Inc.
2 Feb 2026
Miln James
Chief Financial Officer
Sold on a plan 2×
599
$35.33K
0.4%
ARQT Arcutis Biotherapeutics, Inc.
2 Feb 2026
Vairavan Latha
SVP Chief Financial Officer
Sold on a plan
1,320
$33.66K
2.0%
YELP YELP INC
2 Feb 2026
Saldanha Craig
Chief Product Officer
Sold on a plan
1,200
$32.88K
0.6%
VEL Velocity Financial, Inc.
2 Feb 2026
Szczepaniak Mark R
Chief Financial Officer indirect
Sold on a plan
1,573
$32.29K
2.1%
TEM Tempus AI, Inc.
2 Feb 2026
Epstein David R
Director
Sold on a plan
370
$21.98K
1.4%
SER Serina Therapeutics, Inc.
2 Feb 2026
Moreadith Randall
Chief Scientific Officer
Sold on a plan
6,500
$19.68K
100%
FOA Finance of America Companies Inc.
2 Feb 2026
Sieffert Kristen N
President
Sold on a plan
750
$17.49K
0.9%
GRND Grindr Inc.
2 Feb 2026
Richardson Nathan
Director
Sold on a plan
1,500
$16.77K
10.5%
TPET Trio Petroleum Corp
2 Feb 2026
Randall John W.
Director
Sold on a plan
20,000
$12.78K
11.4%
DV DoubleVerify Holdings, Inc.
2 Feb 2026
Grimmig Andrew E
Chief Legal Officer
Sold on a plan
1,000
$10.71K
1.0%
ERII Energy Recovery, Inc.
2 Feb 2026
Yeung William
Chief Legal Officer
Sold on a plan
729
$10.54K
0.9%
IRT INDEPENDENCE REALTY TRUST, INC.
2 Feb 2026
Gebert Richard D
Director
Sold on a plan
500
$8.37K
1.3%
ZNTL Zentalis Pharmaceuticals, Inc.
2 Feb 2026
Vultaggio Vincent
PAO and PFO
Sold on a plan
2,540
$6.48K
1.3%
HGBL Heritage Global Inc.
2 Feb 2026
Sklar James Edward
EVP, Gen Counsel & Secretary
Sold on a plan
3,734
$5.12K
1.4%
Showing 16,001–16,050 of 23,301. ← Newer Page 321 of 467 Older →